Recombinant Rat PUMA Protein，His

PUMA (p53 upregulated modulator of apoptosis) is a pivotal pro-apoptotic protein that plays a significant role in the intrinsic pathway of apoptosis, which is crucial for maintaining cellular homeostasis and preventing tumorigenesis. Initially discovered as a target gene of the tumor suppressor p53, PUMA is known for its ability to promote apoptosis in response to various cellular stressors, including DNA damage and oncogenic signals. Its mechanism of action involves the disruption of mitochondrial membrane integrity by binding to anti-apoptotic Bcl-2 family members, thereby facilitating the activation of caspases and leading to programmed cell death. Research on PUMA has gained traction due to its potential implications in cancer therapy, as targeting the regulatory pathways of PUMA could enhance the effectiveness of existing treatments. Furthermore, studies have shown that PUMA expression is often downregulated in various malignancies, suggesting its role as a crucial player in tumor suppression. Understanding the structural and functional characteristics of PUMA, including its interactions with other apoptotic regulators, is essential for developing novel therapeutic strategies aimed at reactivating its apoptotic potential in cancer cells. This has led to an increased interest in PUMA as a biomarker for cancer prognosis and a target for innovative drugs that can restore its function. As research continues, the insights gained from PUMA studies hold promise not only for advancing cancer treatment but also for uncovering broader mechanisms of apoptosis regulation within cellular contexts.